A study of AZD4063 in PLN R14del dilated cardiomyopathy

Trial Identifier:	D8340C00001
Sponsor:	AstraZeneca
Start Date:	December 2025
Primary Completion Date:	November 2027
Study Completion Date:	November 2027

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
NL	Amsterdam, NL, 1081 HV
NL	Groningen, NL, 9713 GZ
NL	Rotterdam, NL, 3015 GD
NL	Utrecht, NL, 3584 CX

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.